Department of Genetics, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA 19104, USA.
Neurobiol Dis. 2013 Nov;59:257-66. doi: 10.1016/j.nbd.2013.08.001. Epub 2013 Aug 13.
Rett syndrome (RTT) is a neurodevelopmental disorder characterized by developmental regression beginning 6-18months after birth, followed by a lifetime of intellectual disability, stereotyped behaviors, and motor deficits. RTT is caused by mutations in the gene encoding MeCP2, a methyl-CpG binding protein believed to modulate gene transcription. Gene expression studies of individual brain regions have reported that Mecp2 loss-of-function leads to both activation and repression of its gene targets in mice. Conditional deletion of MeCP2 from different brain regions has revealed unique insights into the role of these structures in mediating particular RTT-like phenotypes. However, the function of MeCP2 in the striatum, a major brain region involved in motor control and executive cognitive functions, has yet to be studied. Here, we characterized the gene expression changes in the striatum of Mecp2 mutant mice. We found a number of differentially expressed genes in the striatum of both constitutive Mecp2-null mice and mice lacking MeCP2 only from forebrain GABAergic neurons. These changes only occurred when MeCP2 expression levels had reached mature levels and RTT-like symptoms were manifest, supporting a role for MeCP2 in maintaining proper brain function. Many of the gene expression changes identified in the striatum have not previously been shown to change in the hypothalamus or cerebellum. Bioinformatic analysis of differentially expressed genes in striatum as well as hypothalamus and cerebellum revealed that loss of MeCP2 does not affect the global landscape of gene expression. Additionally, we uncovered a number of differentially expressed genes in the liver of Mecp2-null mice suggesting an important role for MeCP2 in non-neuronal tissues. Collectively, our data suggest that the differential expression of genes following loss of MeCP2 occurs in a tissue- or cell-type specific manner and thus MeCP2 function should be understood in a cellular context.
雷特综合征(RTT)是一种神经发育障碍,其特征是出生后 6-18 个月出现发育倒退,随后终生智力残疾、刻板行为和运动缺陷。RTT 是由编码 MeCP2 的基因突变引起的,MeCP2 是一种甲基-CpG 结合蛋白,被认为可以调节基因转录。对个别脑区的基因表达研究报告称,Mecp2 功能丧失会导致其基因靶标在小鼠中被激活和抑制。从不同脑区条件性删除 MeCP2 揭示了这些结构在介导特定 RTT 样表型方面的独特作用。然而,MeCP2 在纹状体中的功能尚未研究,纹状体是一个参与运动控制和执行认知功能的主要大脑区域。在这里,我们描述了 Mecp2 突变小鼠纹状体的基因表达变化。我们发现,在组成型 Mecp2 缺失小鼠和仅从前脑 GABA 能神经元缺失 MeCP2 的小鼠纹状体中,有许多差异表达的基因。这些变化仅在 MeCP2 表达水平达到成熟水平且出现 RTT 样症状时才会发生,支持 MeCP2 在维持大脑正常功能中的作用。在纹状体中鉴定的许多基因表达变化以前没有在下丘脑或小脑中显示出变化。纹状体、下丘脑和小脑差异表达基因的生物信息学分析表明,MeCP2 的缺失不会影响基因表达的全局景观。此外,我们还发现了 Mecp2 缺失小鼠肝脏中许多差异表达的基因,表明 MeCP2 在非神经元组织中具有重要作用。总之,我们的数据表明,MeCP2 缺失后基因的差异表达以组织或细胞类型特异性的方式发生,因此应该在细胞背景下理解 MeCP2 的功能。